Allyx Therapeutics Awarded $3.3 Million NIH Grant For ALX-001
15 Oct 2024 //
GLOBENEWSWIRE
Allyx Treats First Parkinson`s Patient With ALX-001
04 Sep 2024 //
GLOBENEWSWIRE
Allyx Therapeutics Announces First Alzheimer’s Disease Patient Treated ALX-001
11 Jun 2024 //
GLOBENEWSWIRE
Allyx Announces Positive Phase 1b Data and Advances ALX-001
11 Mar 2024 //
GLOBENEWSWIRE
Allyx Announces Expansion into Parkinsons Disease Clinical Research
05 Mar 2024 //
GLOBENEWSWIRE